Black Education and Treatment of Hypertension (BEAT HTN)
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Clinical trials have yet to test the adequacy of HTN control in African Americans (AA) when
both control and intervention groups are given free antihypertensive medications and are
involved in usual versus intensive intervention strategies. Because of this, it has not yet
been determined whether the method of prescribing antihypertensive medications according to
JNC 7 guidelines is more, less, or equally as effective as prescribing antihypertensive
medications and providing intensive behavioral and clinical interventions. Knowledge in this
area of HTN treatment should better able medical and health practitioners to help their AA
subjects control HTN. The BEAT Hypertension Clinic will evaluate this method of HTN control
by proposing a program that will evaluate the difference in HTN control among subjects
receiving usual care and free medications and subjects also receiving free medications, but
additionally being treated in a clinic that operates in a more intensive manner in
relationship to patient behavior modification, patient-clinician interactions, and physical
and social environments. At the conclusion of the study, the BEAT Hypertension Clinic
investigators will report findings and help to answer the question of whether medication
alone or medication combined with intensive behavioral and clinical treatment is more
effective in HTN control in the AA population.